Date: Thursday, December 02, 2021

Time: 01:00 PM Eastern Standard Time

Dr. Ravindra Mehta, an internationally recognized nephrologist, will discuss a multi-country, International Society of Nephrology (ISN) sponsored study demonstrating that a comprehensive program of point-of-care creatinine/eGFR testing, urine dipstick testing, and protocolized care management can improve the recognition of AKI in low-resource settings, improve clinical outcomes, and reduce the overall costs of treating kidney disease. Dr. Mehta was the lead author and investigator of the study.

Dr. Begos will highlight the utility and accuracy of Nova StatSensor Creatinine/eGFR for kidney function screening in multiple settings.Speakers

Dr. Ravindra Mehta, MD

Dr. Ravindra Mehta, MD
Professor of Medicine, Division of Nephrology
UCSD Department of Medicine

Dennis Begos, MD, FACS, FACRS

Dennis Begos, MD, FACS, FACRS
Medical Director, Medical and Scientific Affairs
Nova Biomedical